EG668381 inhibitors are a class of chemical compounds characterized by their ability to specifically interact with and modulate the activity of certain cellular enzymes. These inhibitors are typically small molecules that possess structural features allowing them to bind selectively to the active sites or allosteric sites of their target enzymes, leading to the alteration of the enzyme's function. The structural design of EG668381 inhibitors is often based on a core scaffold that facilitates high binding affinity and selectivity toward the target protein. This scaffold is then further optimized through the addition of various functional groups, which can enhance properties such as solubility, binding dynamics, and metabolic stability. The high specificity of EG668381 inhibitors is particularly beneficial in achieving targeted modulation of cellular processes without affecting unrelated enzymes, thereby minimizing off-target interactions.
The biochemical activity of EG668381 inhibitors largely centers around the modulation of enzymatic pathways, which can result in changes to downstream signaling and cellular processes. Due to their precise targeting capabilities, these inhibitors are valuable tools for dissecting cellular signaling pathways and understanding enzyme function within a biological context. By binding to their specific targets, they can either block or enhance enzyme activity, providing insights into the mechanisms governing cellular function and the role of the targeted enzymes in various physiological contexts. The development and characterization of EG668381 inhibitors involve extensive biochemical assays to determine their binding affinity, selectivity, and ability to influence the catalytic activity of the target enzyme. Their study not only contributes to a deeper understanding of enzyme regulation but also advances the broader field of chemical biology by providing novel compounds that can be used to manipulate cellular mechanisms in research settings.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
Glucocorticoid receptor agonist that can suppress transcription factors involved in secretoglobin expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Histone deacetylase inhibitor that can alter chromatin structure and influence gene expression, including that of secretoglobins. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor that can change DNA methylation patterns, potentially affecting secretoglobin gene expression. | ||||||
Kenpaullone | 142273-20-9 | sc-200643 sc-200643A sc-200643B sc-200643C | 1 mg 5 mg 10 mg 25 mg | $60.00 $150.00 $226.00 $495.00 | 1 | |
GSK-3 inhibitor that can influence Wnt signaling and thereby potentially alter secretoglobin gene expression. | ||||||
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $67.00 $306.00 | 2 | |
Another GSK-3 inhibitor with similar effects on Wnt signaling and potential impact on secretoglobin expression. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $92.00 $260.00 | 42 | |
CDK inhibitor that can affect cell cycle progression and influence gene expression, including of secretoglobins. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
Inhibitor of TGF-β receptor kinase that can modulate TGF-β signaling pathways, potentially affecting secretoglobin expression. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $62.00 $112.00 $214.00 $342.00 | 74 | |
EGFR tyrosine kinase inhibitor that can affect cell signaling pathways related to secretoglobin expression. | ||||||
Chetomin | 1403-36-7 | sc-202535 sc-202535A | 1 mg 5 mg | $182.00 $661.00 | 10 | |
Disrupts HIF-1α/p300 interaction, potentially affecting hypoxia-related gene expression, including secretoglobins. | ||||||
A 83-01 | 909910-43-6 | sc-203791 sc-203791A | 10 mg 50 mg | $198.00 $795.00 | 16 | |
Selective inhibitor of TGF-β type I receptor ALK5 kinase, which can influence TGF-β signaling and secretoglobin gene expression. |